The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans (Q45403866)

14 December 2017

title

The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans (English)

1 reference

14 December 2017

1 reference

1 reference

9

John Aaskov

1 reference

14 December 2017

8

Friedrich Dorner

1 reference

14 December 2017

1

Otfried Kistner

1 reference

14 December 2017

6

Helga Savidis-Dacho

1 reference

14 December 2017

Noel Barrett

2

1 reference

14 December 2017

Axel Brühmann

3

1 reference

14 December 2017

Manfred Reiter

4

1 reference

14 December 2017

Wolfgang Mundt

5

1 reference

14 December 2017

Susanne Schober-Bendixen

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

12 February 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

25

1 reference

14 December 2017

issue

25

1 reference

14 December 2017

page(s)

4845-4852

1 reference

An Epidemic of Ross River Virus Infection in Fiji, 1979

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Epidemic Polyarthritis (Ross River) Virus Infection in the Cook Islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Ross River virus (Togaviridae: Alphavirus) infection (epidemic polyarthritis) in American Samoa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Surveillance for Ross River virus infection using blood donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Development of a candidate vaccine against Ross River virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

A candidate Ross River virus vaccine: preclinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Reaction of β-propiolactone with amino acids and its specificity for methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Specific quantitation of genomic DNA in the femtogram range by amplification of repetitive sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Protection against Japanese encephalitis by inactivated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Neutralizing antiviral B cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

Specific and non-specific immunological changes in epidemic polyarthritis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

inferred from DOI database lookup

7 January 2021

based on heuristic

Isolation of Ross River virus from epidemic polyarthritis patients in Australia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.103

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.01.103

1 reference

14 December 2017

1 reference